Drug discovery
Viewpoint: Pricey gene therapies fuel debate over drug prices—and why there is no easy fix
By scrapping value added and sales taxes, we can cut down on drug pricing by up to 25% ...
Viewpoint: Price controls would stifle private sector innovation that gives us most of our new biomedical drugs
The false maxim that the government is primarily responsible for all innovation has been refuted through published literature in peer-reviewed ...
Viewpoint: AI can revolutionize drug development if we can learn to trust it
The pharmaceutical industry is facing a crisis is R&D. About 50% of late-stage clinical trials fail due to ineffective drug targets, ...
Speeding up drug research through ‘visionary’ cryptographic crowdsourcing
A new cryptographic system could allow pharmaceutical companies and academic labs to work together to develop new medications more quickly ...